Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
EventsCongratulations to our co-founder Mickael Tanter on his election to the French Academy of Sciences! Jun 26, 2025 READ MORE
Press ReleaseCardiawave annonce les résultats positifs à 12 mois de ses études “Valvosoft® FIM Study” et « Valvosoft® Pivotal Study » à l’EuroPCR! May 23, 2025 READ MORE
Press Release Cardiawave announces first routine treatments performed with Valvosoft® following CE Mark approval and accelerates its deployment Jun 16, 2026 HeleneCardiawave 0
About Us First treatments with Valvosoft® now performed in routine clinical practice in Germany 🚀 Jun 11, 2026 HeleneCardiawave 0
